Literature DB >> 15832228

Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.

K Fritsch1, M-L Jacot, A Klarer, F Wick, P Bruggmann, M Krause, R Thurnheer.   

Abstract

QUESTIONS UNDER STUDY: Swiss guidelines for the management of chronic obstructive pulmonary disease (COPD) were published in 2002. We aimed at assessing adherence to the proposed guidelines by the physicians in charge for all patients referred to our hospital for acute exacerbations of COPD over a one year period.
METHODS: In a prospective observational study, data from a questionnaire and from records of all patients referred to our hospital with acute exacerbation of COPD were collected. Diagnostic steps as well as therapeutic and prophylactic interventions were reviewed. Where applicable, interventions were stratified according to proposed levels of evidence A-D.
RESULTS: 45 patients in whom the diagnosis of COPD had been made before were included. Diagnosis was established by spirometry in 71%, in the remaining diagnosis was based on clinical grounds only. Non-smoking advice was given to 69%, and 16% were offered a nicotine-replacement trial (level A). Information about a disease management plan was given in 40% of the patients (level B), 22% had done a six minute walking distance test. 27% of the patients had participated in a pulmonary rehabilitation program (level A). 93% were on regular bronchodilator therapy (level B), and 56% had regular inhaled corticosteroids (level B).
CONCLUSION: Confirmation of the diagnosis of COPD by spirometry is lacking in a significant number of patients. Most patients were treated with regular bronchodilators, however, relevant over-treatment with beta-adrenergic substances and overuse of inhaled corticosteroids in mild disease stages are common. Efforts for disease prevention and education as well as awareness of the potential benefits of pulmonary rehabilitation programs are still insufficient. Efforts to improve the adherence to the Swiss guidelines for the management of COPD should be intensified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832228     DOI: 2005/07/smw-10844

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  9 in total

1.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

2.  ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study.

Authors:  Lara Siebeling; Gerben ter Riet; Willem M van der Wal; Ronald B Geskus; Marco Zoller; Patrick Muggensturm; Irena Joleska; Milo A Puhan
Journal:  BMC Pulm Med       Date:  2009-05-06       Impact factor: 3.317

3.  Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial.

Authors:  Jenifer Liang; Michael J Abramson; Nicholas Zwar; Grant Russell; Anne E Holland; Billie Bonevski; Ajay Mahal; Benjamin van Hecke; Kirsten Phillips; Paula Eustace; Eldho Paul; Kate Petrie; Sally Wilson; Johnson George
Journal:  BMJ Open       Date:  2017-09-18       Impact factor: 2.692

4.  Pulmonary rehabilitation in COPD - available resources and utilization in Swedish primary and secondary care.

Authors:  Josefin Sundh; Helena Lindgren; Mikael Hasselgren; Scott Montgomery; Christer Janson; Björn Ställberg; Karin Lisspers
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-06-08

5.  Advanced nursing practice in COPD exacerbations: the solution for a gap in Switzerland?

Authors:  Gabriela Schmid-Mohler; Christian Clarenbach; Gabi Brenner; Malcolm Kohler; Eva Horvath; Marc Spielmanns; Heidi Petry
Journal:  ERJ Open Res       Date:  2020-06-15

6.  The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year.

Authors:  Kuo-Chen Cheng; Chih-Cheng Lai; Cheng-Yi Wang; Ching-Min Wang; Chung-Han Ho; Mei-I Sung; Shu-Chen Hsing; Kuang-Ming Liao; Shian-Chin Ko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-21

7.  Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Authors:  Milo A Puhan; Lucas M Bachmann; Jos Kleijnen; Gerben Ter Riet; Alphons G Kessels
Journal:  BMC Med       Date:  2009-01-14       Impact factor: 8.775

8.  Antibiotics used in the ambulatory management of acute COPD exacerbations.

Authors:  Marie-France Beauchesne; Marcel Julien; Louis-André Julien; Dominique Piquette; Amélie Forget; Manon Labrecque; Lucie Blais
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

9.  Clinical and individual factors associated with smoking quit attempts among adults with COPD: do factors vary with regard to race?

Authors:  Dana S Mowls; Vinay K Cheruvu; Melissa D Zullo
Journal:  Int J Environ Res Public Health       Date:  2014-04-03       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.